New Zealand offers a different destination for clinical trials to take place, but with a familiar ethnicity to the participants providing pertinent data which can be applied to a standard North American and European demographic with a very similar set of regulatory requirements. The only factor which might limit participation is the distance and time difference, which should not be a barrier for any practical purposes. Sue Lee at World Courier discusses the potential of New Zealand.
Watch 3 – Newzealand